CDC director nominee Erica Schwartz faced questions in Senate hearing – NPR

Erica Schwartz appeared before a Senate committee on July 15, 2026, for a confirmation hearing regarding her nomination to lead the Centers for Disease Control and Prevention (CDC). The proceedings focused on her qualifications and the agency’s future priorities, according to reporting from NPR.

The hearing serves as a critical step in the federal appointment process, where senators question the nominee’s approach to public health crises and administrative management. Schwartz’s testimony is intended to establish her policy positions before the nomination moves to a full Senate vote.

The CDC, headquartered in Atlanta, Georgia, is the primary national public health agency of the United States. Its leadership is tasked with monitoring disease outbreaks, coordinating emergency responses, and issuing health guidelines to state and local governments.

During the session, lawmakers queried Schwartz on her strategy for handling emerging infectious threats and her plans for agency transparency. The line of questioning reflected ongoing congressional scrutiny over how the CDC communicates scientific data to the public during national emergencies.

The Senate hearing process allows committee members to vet the nominee’s professional history and ensure the candidate can maintain the agency’s operational independence from political influence. According to NPR, the questions faced by Schwartz were centered on her ability to lead the organization through evolving health challenges.

Following the conclusion of the hearing, the committee will determine whether to report the nomination favorably to the full Senate. If the committee approves her, a floor vote will be scheduled to confirm her appointment as the director of the CDC.